Articles

The 5-HT2A Receptor Antagonist M100907 Produces Antiparkinsonian Effects and Decreases Striatal Glutamate

• Twum Ansah
• Marcus Ferguson
• Tultul Nayyar

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease

in Neuropharmacology

• Tian-Jiao Chen
• Ya Feng
• Te Liu
• Ting-Ting Wu
• Ya-Jing Chen
• Xuan Li
• Qing Li
• Yun-Cheng Wu

Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease

in Neurodegeneration

• Mei-Fang Liu
• Yan Xue
• Cui Liu
• Yun-Hai Liu
• Hui-Ling Diao
• Ying Wang
• Yi-Peng Pan
• Lei Chen

Epigenetic regulation of the respiratory chain by a mitochondrial distress-related redox signal

in Signaling

• Marius W. Baeken
• Ankush Borlepawar
• Philipp Kötzner
• Holger Richly
• Christian Behl
• Bernd Moosmann
• Parvana Hajieva

Lipostatic Mechanisms Preserving Cerebellar Lipids in MPTP-Treated Mice: Focus on Membrane Microdomains and Lipid-Related Gene Expression

in Molecular Signalling and Pathways

• Mario Díaz
• Ana Canerina Luis-Amaro
• Deiene Rodriguez Barreto
• Verónica Casañas-Sánchez
• José A. Pérez
• Raquel Marin

MiR-30c-5p/ATG5 Axis Regulates the Progression of Parkinson’s Disease

in Cellular Neuropathology

• Li Zhang
• Xiufen Chen
• Mingxiu Chang
• Boning Jiao

LY354740 Reduces Extracellular Glutamate Concentration, Inhibits Phosphorylation of Fyn/NMDARs, and Expression of PLK2/pS129 α-Synuclein in Mice Treated With Acute or Sub-Acute MPTP

in Neuropharmacology

• Yang Tan
• Yan Xu
• Chi Cheng
• Cong Zheng
• Weiqi Zeng
• Ji Wang
• Xiaoqian Zhang
• Xiaoman Yang
• Jialing Wang
• Xiaomei Yang

Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders

in Translational Pharmacology

• Kenji Hashimoto

Cross-species validation of a 6-miRNA blood signature for Parkinson’s disease: from MPTP mice to human PBMC and serum exosomes

in Dementia and Neurodegenerative Diseases

• Nagyum Jung
• Seung-Nam Kim